Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors

Completed · Phase 2 · Has a placebo group

Conditions studied: Gastroesophageal Reflux

In brief

This study is meant to assess the effect of IW-3718 as an added treatment to ongoing once-daily protocol pump inhibitor (PPI) treatment for patients who continue to experience symptoms of their gastroesophageal reflux disease (GERD).

Key facts

Study ID
NCT02030925
Run by
Ironwood Pharmaceuticals, Inc.
People needed
93
Starts
2014-02-01
Expected to finish
2014-12-01
Last updated by the study team
2016-08-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.